Zola Chihombori Quao1, Mancy Tong1, Elena Bryce1,2, Seth Guller1, Lawrence W Chamley3, Vikki M Abrahams1. 1. Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University, New Haven, CT, USA. 2. Albert Einstein College of Medicine, Bronx, NY, USA. 3. Department of Obstetrics & Gynecology, University of Auckland, Auckland, New Zealand.
Abstract
PROBLEM: Women with antiphospholipid antibodies (aPL) are at risk for pregnancy complications despite treatment with low molecular weight heparin (LMWH) or aspirin (ASA). aPL recognizing beta2 glycoprotein I can target the uterine endothelium, however, little is known about its response to aPL. This study characterized the effect of aPL on human endometrial endothelial cells (HEECs), and the influence of LMWH and ASA. METHOD OF STUDY: HEECs were exposed to aPL or control IgG, with or without low-dose LMWH and ASA, alone or in combination. Chemokine and angiogenic factor secretion were measured by ELISA. A tube formation assay was used to measure angiogenesis. RESULTS: aPL increased HEEC secretion of pro-angiogenic VEGF and PlGF; increased anti-angiogenic sFlt-1; inhibited basal secretion of the chemokines MCP-1, G-CSF, and GRO-α; and impaired angiogenesis. LMWH and ASA, alone and in combination, exacerbated the aPL-induced changes in the HEEC angiogenic factor and chemokine profile. There was no reversal of the aPL inhibition of HEEC angiogenesis by either single or combination therapy. CONCLUSION: By aPL inhibiting HEEC chemokine secretion and promoting sFlt-1 release, the uterine endothelium may contribute to impaired placentation and vascular transformation. LMWH and ASA may further contribute to endothelium dysfunction in women with obstetric APS.
PROBLEM: Women with antiphospholipid antibodies (aPL) are at risk for pregnancy complications despite treatment with low molecular weight heparin (LMWH) or aspirin (ASA). aPL recognizing beta2 glycoprotein I can target the uterine endothelium, however, little is known about its response to aPL. This study characterized the effect of aPL on human endometrial endothelial cells (HEECs), and the influence of LMWH and ASA. METHOD OF STUDY: HEECs were exposed to aPL or control IgG, with or without low-dose LMWH and ASA, alone or in combination. Chemokine and angiogenic factor secretion were measured by ELISA. A tube formation assay was used to measure angiogenesis. RESULTS: aPL increased HEEC secretion of pro-angiogenic VEGF and PlGF; increased anti-angiogenic sFlt-1; inhibited basal secretion of the chemokines MCP-1, G-CSF, and GRO-α; and impaired angiogenesis. LMWH and ASA, alone and in combination, exacerbated the aPL-induced changes in the HEEC angiogenic factor and chemokine profile. There was no reversal of the aPL inhibition of HEEC angiogenesis by either single or combination therapy. CONCLUSION: By aPL inhibiting HEEC chemokine secretion and promoting sFlt-1 release, the uterine endothelium may contribute to impaired placentation and vascular transformation. LMWH and ASA may further contribute to endothelium dysfunction in women with obstetric APS.
Authors: Caroline R Albert; William J Schlesinger; Chez A Viall; Melissa J Mulla; Jan J Brosens; Lawrence W Chamley; Vikki M Abrahams Journal: Am J Reprod Immunol Date: 2013-12-11 Impact factor: 3.886
Authors: Melissa J Mulla; Jane E Salmon; Larry W Chamley; Jan J Brosens; Crina M Boeras; Paula B Kavathas; Vikki M Abrahams Journal: PLoS One Date: 2013-06-06 Impact factor: 3.240
Authors: Cheng-Hsuan Wu; Tsung-Hsien Lee; Shun-Fa Yang; Hui-Mei Tsao; Yu-Jun Chang; Chia-Hsuan Chou; Maw-Sheng Lee Journal: Int J Environ Res Public Health Date: 2019-03-19 Impact factor: 3.390
Authors: Manuela Velásquez; Luisa F Peláez; Mauricio Rojas; Raúl Narváez-Sánchez; Jesús A Velásquez; Carlos Escudero; Sebastián San Martín; Ángela P Cadavid Journal: Front Physiol Date: 2021-12-02 Impact factor: 4.566